“…Many studies have been performed on choosing good-quality oocytes and embryos for ICSI patients, and several articles have been published on growth factors, hormones, reactive oxygen species (ROS) production, apoptosis, and gap junctional complexes on the adjacent follicular cells in patients undergoing ICSI [8,[10][11][12][13][14][15]. Currently, there is increasing interest in signaling pathways (e.g., Wnt, Hedgehog, and Notch pathways) that are important for developing oocytes.…”